Literature DB >> 17119640

Birch bark research and development.

Pavel A Krasutsky1.   

Abstract

This review will detail progress made in the previous decade on the chemistry and bioactivity of birch bark extractive products. Current and future applications of birch bark natural products in pharmaceuticals, cosmetics, and dietary supplements for the prevention and treatment of cancer, HIV,and other human pathogens are reviewed. Current developments in the technology of birch bark processing are discussed. New approaches for the synthesis of potentially valuable birch bark triterpenoid derivatives are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119640     DOI: 10.1039/b606816b

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  41 in total

1.  New ionic derivatives of betulinic acid as highly potent anti-cancer agents.

Authors:  Challa Suresh; Hua Zhao; Angelique Gumbs; Chellu S Chetty; Himangshu S Bose
Journal:  Bioorg Med Chem Lett       Date:  2011-12-28       Impact factor: 2.823

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Birch tar production does not prove Neanderthal behavioral complexity.

Authors:  Patrick Schmidt; Matthias Blessing; Maxime Rageot; Radu Iovita; Johannes Pfleging; Klaus G Nickel; Ludovic Righetti; Claudio Tennie
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

4.  Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors.

Authors:  Hua Zhao; Shaletha S Holmes; Gary A Baker; Suresh Challa; Himangshu S Bose; Zhiyan Song
Journal:  J Enzyme Inhib Med Chem       Date:  2011-10-10       Impact factor: 5.051

5.  Pharmacokinetics and Tissue Disposition of Nanosystem-Entrapped Betulin After Endotracheal Administration to Rats.

Authors:  Olga N Pozharitskaya; Marina V Karlina; Alexander N Shikov; Vera M Kosman; Valery G Makarov; Eudald Casals; Jessica M Rosenholm
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

6.  Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication.

Authors:  Casey R Dorr; Sergiy Yemets; Oksana Kolomitsyna; Pavel Krasutsky; Louis M Mansky
Journal:  Bioorg Med Chem Lett       Date:  2011-01-01       Impact factor: 2.823

7.  Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase.

Authors:  Robert J Visalli; Hannah Ziobrowski; Kameswara R Badri; Johnny J He; Xiugen Zhang; Sri Ranjini Arumugam; Hua Zhao
Journal:  Bioorg Med Chem Lett       Date:  2015-06-06       Impact factor: 2.823

8.  Identification and isolation of pharmacologically active triterpenes in Betuale cortex, Betula pendula Roth., Betulaceae.

Authors:  Elvira E Kovac-Besović; Kemal Durić; Zdenka Kalodera; Emin Sofić
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

9.  Evaluation of A-azepano-triterpenoids and related derivatives as antimicrobial and antiviral agents.

Authors:  Oxana Kazakova; Elena Tret'yakova; Dmitry Baev
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

10.  Preparation and Characterization of Electrospun Polylactic Acid (PLA) Fiber Loaded with Birch Bark Triterpene Extract for Wound Dressing.

Authors:  Tianyuan Fan; Rolf Daniels
Journal:  AAPS PharmSciTech       Date:  2021-07-20       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.